
    
      The present clinical study will assess safety, tolerability and pharmacokinetics of SB-649868
      20mg administered for 28 consecutive days in adult (18 to 65 yrs old) and elderly (>65 yrs
      old) men and women. The study will also assess cardiac function using echocardiography.
    
  